Oct 05, 2023 8:00 am EDT BullFrog AI Announces Identification of Novel Potential Drug Targets for Colorectal Cancer Using Its AI-Driven bfLEAP™ Platform
Sep 26, 2023 8:00 am EDT BullFrog AI Announces Positive Data from Preclinical Study Evaluating Novel Prodrug of Mebendazole for Treatment of Glioblastoma
Sep 25, 2023 8:00 am EDT BullFrog AI Founder and CEO Vin Singh to Present Company Overview at BioFuture 2023
Sep 20, 2023 8:00 am EDT BullFrog AI Announces Launch of BullFrog Data Networks™, a Data Insights Tool Powered by the bfLEAP™ Platform
Sep 14, 2023 4:30 pm EDT BullFrog AI Founder and CEO Vin Singh to Present Company Overview at Maxim Group’s Emerging Growth in AI Virtual Tech Conference Series
Sep 13, 2023 7:01 am EDT BullFrog AI Announces Three-Year Global Strategic Partnership with the Lieber Institute for Brain Development
Sep 07, 2023 4:05 pm EDT BullFrog AI Announces Investor Webinar with CEO and Founder Vin Singh on Thursday, September 14, 2023
Aug 23, 2023 8:00 am EDT BullFrog AI Technology Licensed from Johns Hopkins University APL Named Finalist in R&D 100 Awards
Jul 25, 2023 7:30 am EDT BullFrog AI Announces Issuance of U.S. Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating Cancer